Skip to Main Content

Optimizing prostate MRI for advanced clinical insights

OnQ Prostate is an FDA-cleared software solution using Restriction Spectrum Imaging (RSI), a patented diffusion MRI method that has been shown to improve detection, in vivo characterization, and localization of clinically significant cancer.

Improved accuracy for quality reads

Through clear, easy-to-interpret images OnQ™ Prostate empowers collaborative decision-making and enhances targeting for biopsy and therapy. Elevating clinical workflows that use MRI for prostate cancer detection, monitoring, and treatment, it helps bridge the gaps between radiologists and referring physicians.


Detection and prediction

Of clinically significant cancer

Improved tumor conspicuity

And differentiation from non-tumor

Stronger histopathology correlation

Based on Gleason Score

AI radiology news

Stay up to date with the latest insights, advances and clinical applications